Journal of Urologic Oncology

Search

Page Path

HOME
Search

Review Article

Animal Models for Bone Metastatic Prostate Cancer: Woo Hyeok Jeon, Cheeun Song, Seung Ju Jang, Sejung Maeng, In Ho Chang, Jong Hyun Tae; Korean J Urol Oncol. 2022;20(4):248-256. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.248; Full text PubReader ePub PDF

Review Article

Nanomedicines for Therapy of Bladder Cancer: Cheeun Song, Seung Ju Jang, Woo Hyeok Jeon, Sejung Maeng, Jong Hyun Tae, In Ho Chang; Korean J Urol Oncol. 2022;20(4):235-247. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.235; Full text PubReader ePub PDF

Review Article

Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma: Jeong Yoon Suh, Se Jung Maeng, Mirinae Kim, Su Jeong Kang, Young Wook Choi, In Ho Chang; Korean J Urol Oncol. 2022;20(4):223-234. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.223
Cited By 1; Full text PubReader ePub PDF

Review Article

Artificial Intelligence on Urology Lab: Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, Sungyun Park, Ruei Ting Wang, Taewoo Kim, Ji Eun Koh, Jong Hyun Tae, In Ho Chang, Se Young Choi; Korean J Urol Oncol. 2022;20(3):163-176. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.163; Full text PubReader ePub PDF

Review Article

The Present and Future of Intravesical Therapy in Bladder Cancer: Sin-Woo Seong, Youngjae Shin, In Ho Chang, Jung Hoon Kim; Korean J Urol Oncol. 2022;20(2):82-91. Published online May 26, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.2.82; Full text PubReader ePub PDF

Erratum: Addition of the Co-author

Patient-Specific Tumor Microenvironment Models: Jung Woo Lee, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim, In Ho Chang, Se Young Choi; Korean J Urol Oncol. 2022;20(1):69-69. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.69
Corrects: J Urol Oncol 2021;19(4):197; Full text PubReader ePub PDF

Review Article

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Jaewoon Jeong, Jae Baek Ha, In Ho Chang; Korean J Urol Oncol. 2022;20(1):12-24. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.12; Full text PubReader ePub PDF

Review Article

Clinical Implications of Urinary Microbiome in Bladder Cancer: Jae Hun Shim, Joon Hee Gook, In Ho Chang, Jung Min Sohn, Sin Woo Seong, Byung Hoon Chi; Korean J Urol Oncol. 2021;19(2):71-78. Published online May 31, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.2.71; Full text PubReader ePub PDF

Original Article

The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model: Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, Se Young Choi, Byung Hoon Chi, In Ho Chang; Korean J Urol Oncol. 2021;19(1):40-47. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.40
Cited By 1; Full text PubReader ePub PDF

Review Article

The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment: Da Som Choi, Su Jeong Kang, In Ho Chang, Young Wook Choi; Korean J Urol Oncol. 2021;19(1):30-39. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.30; Full text PubReader ePub PDF

Review Article

Approaches for Personalized Drug Development in Bladder Cancer Patients: Hyang Sook Seol, In Ho Chang; Korean J Urol Oncol. 2020;18(2):91-98. Published online August 27, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.2.91; Full text PubReader ePub PDF

Review Article

Bacillus Calmette-Guérin (BCG)-Cell Wall Skeleton as Immunotherapeutic Option for BCG-Refractory Superficial Bladder Cancer: Young Mi Whang, Da Hyeon Yoon, Gwang Yong Hwang, Young Wook Choi, In Ho Chang; Korean J Urol Oncol. 2019;17(2):88-95. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.88; Full text PubReader ePub PDF

Review Article

The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers: Gwang Yong Hwang, Se Young Choi, In Ho Chang; Korean J Urol Oncol. 2019;17(2):75-80. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.75; Full text PubReader ePub PDF

Review Article

Application of Bioprinting to Cancer Research: Min Ji Cho, Byung Hoon Chi, Myeong Joo Kim, Young Mi Whang, In Ho Chang; Korean J Urol Oncol. 2018;16(2):52-57. Published online August 31, 2018; DOI: https://doi.org/10.22465/kjuo.2018.16.2.52
Cited By 1; Full text PubReader ePub PDF

Review Article

The Overdiagnosis of Kidney Cancer in Koreans and the Active Surveillance on Small Renal Mass: Byung Hoon Chi, In Ho Chang; Korean J Urol Oncol. 2018;16(1):15-24. Published online April 27, 2018; DOI: https://doi.org/10.22465/kjuo.2018.16.1.15
Cited By 1; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

5,578	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,030	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,372	The Present and Future of Intravesical Therapy in Bladder Cancer
4,321	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,296	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.